Skip to main navigation
Skip to search
Skip to main content
Scholars @ UT Health San Antonio Home
Help & FAQ
English
Español
Home
Profiles
Research Units
Research output
Search by expertise, name or affiliation
Second cancers following antineoplastic therapy
F. Andrew Dorr, Charles A. Coltman
Research output
:
Contribution to journal
›
Article
›
peer-review
18
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Second cancers following antineoplastic therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Combination Therapy
100%
Man
80%
Carcinogenesis
60%
Malignant Neoplasm
60%
Therapeutic Procedure
60%
Cancer
60%
Diseases
40%
Radiation Therapy
40%
Intensive Care
40%
Dose Response
40%
Radiation
40%
Toxicity
20%
Survival Rate
20%
Anticarcinogen
20%
Exercise
20%
Treatment Duration
20%
Alkylating Antineoplastic Agent
20%
Leukemia
20%
Radiation Exposure
20%
Second Cancer
20%
Hodgkin's Lymphoma
20%
Evolution
20%
Cancer Therapy
20%
Procarbazine
20%
ABVD
20%
Survival
20%
Comprehension
20%
Absence
20%
Nursing and Health Professions
Combination Therapy
100%
Patient
80%
Malignant Neoplasm
60%
Carcinogenesis
60%
Diseases
40%
Intensive Care
40%
Chemotherapy
40%
Radiotherapy
40%
Physician
20%
Survival Rate
20%
Toxicity
20%
Treatment Duration
20%
Hodgkin Disease
20%
Second Cancer
20%
Cancer Therapy
20%
Anticarcinogen
20%
Electric Potential
20%
Absence
20%
Time
20%
Survival
20%
Alkylating Agent
20%
Dose
20%
Radiation Exposure
20%
Procarbazine
20%
Pharmacology, Toxicology and Pharmaceutical Science
Carcinogenesis
60%
Malignant Neoplasm
60%
Diseases
40%
Anticarcinogen
20%
Toxicity
20%
Combination Therapy
20%
Hodgkin Disease
20%
Survival Rate
20%
Radiation Exposure
20%
Procarbazine
20%
Alkylating Agent
20%
Second Cancer
20%
Absence
20%
Survival
20%
Neuroscience
Carcinogenesis
40%
Chemotherapy
40%
Procarbazine
20%
ABVD
20%